Leronlimab Shows Inhibits Colon Carcinoma Metastases to Liver & Lung in Preclinical Studies: Can the Sponsor Finance Clinicals?

Leronlimab Shows Inhibits Colon Carcinoma Metastases to Liver & Lung in Preclinical Studies: Can the Sponsor Finance Clinicals?

CytoDyn’s PRO 140, a CCR5 antagonist called leronlimab, inhibited a human colon carcinoma cell line, SW480, metastases to liver and lung in a well-accepted mouse model in pre-clinical research phase. Cytodyn, a small emerging biotech, was recently cleared by the FDA...

Pin It on Pinterest